[HTML][HTML] Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy
M Bagheri, MA Zandieh, M Daryab, SS Samaei… - Translational …, 2024 - Elsevier
As a clinically approved treatment strategy, chemotherapy-mediated tumor suppression has
been compromised, and in spite of introducing various kinds of anticancer drugs, cancer …
been compromised, and in spite of introducing various kinds of anticancer drugs, cancer …
ETS transcription factor ELK3 in human cancers: An emerging therapeutic target
Cancer is a genetic and complex disorder, resulting from several events associated with
onset, development, and metastasis. Tumor suppressors and oncogenes are among the …
onset, development, and metastasis. Tumor suppressors and oncogenes are among the …